In contrast, second-generation AKI biomarkers, including stress markers such as tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7), have been developed primarily in the past 10 years [11]. The gene discussed is TIMP2; the disease is acute kidney injury.